> CPDR News
CPDR Takes Five Awards
February 2, 2009
The 56th James C. Kimbrough Urological Seminar brought great recognitions to CPDR. This year the seminar was held in Washington DC.
COL (Ret.) David G.McLeod was honored with the H. G. Stevenson award. In 1992 the Society of Government Service Urologists established this award, which is presented annually for outstanding support and dedicated service to the Society. The recipient of this award can be a Corporate Member, physician, or other individual as determined by the Board of Directors.
Read the full article
CPDR Director, Dr. David G. McLeod, is Guest Blogger on WebMD
October 20, 2008
CPDR Director, Dr. David G. McLeod, posted an article titled, “Prostate Cancer: Know the Risk Factors,” to WebMD’s blog site, in collaboration with Dr. Ward Casscells, the Assistant Secretary of Defense of Health Affairs (ASD-HA). The blog post presents a look at the risk factors of Prostate Cancer and highlights the Center for Prostate Disease Research, under the leadership of Dr. McLeod.
Read the full article
USU’s Center for Prostate Disease Research Provides New Insights Into Common Alterations of ERG
Oncogene in Prostate Cancer
Monday, October 6, 2008
BETHESDA, Md. — In the past three years, ground-breaking discoveries in the prostate cancer field have highlighted that alterations of ETS related genes (predominantly ERG), as a result of a fusion between male hormone receptor regulated gene promoters (predominantly TMPRSS2) and ETS transcription factors, represent one of the most common oncogenic defects in prostate cancer. Researchers at the Center for Prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU) had originally shown frequent overexpression (60-70%) of the ETS related gene ERG in the epithelial cell transcriptome of prostate cancers. In their continued quest to understand the functional role and clinical utility of ERG alterations in prostate cancer, CPDR researchers have now defined new features of ERG function and expression which will further enhance the potential of ERG as promising biomarker and therapeutic target for prostate cancer.
Full Article
USU’s Center for Prostate Disease Research Reports New Prognostic Utility of PCA3 Molecular Urine Test
Monday, October 6, 2008
BETHESDA, Md. — In a recent report, the collaborative research team from the Center for Prostate Disease Research at the Uniformed Services Universit of the Health Sciences (USU) and Walter Reed Army Medical Center (WRAMC) and Gen-Probe Inc., San Diego, Calif., showed a new promising prognostic utility of the urine PCA3 test.
Full Article
USU’s Center for Prostate Disease Research Unravels New Aspects of the Male Hormone (Androgen) Receptor Regulation in Prostate Cancer
Monday, October 6, 2008
BETHESDA, Md. — A team of researchers in the Center for Prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU), led by Dr. Shiv Srivastava, professor of surgery, are working to define male hormone regulated transcriptome in prostate cancer cells.
Full Article
USU’s Center for Prostate Disease Research, University of the
District of Columbia Launch Successful Summer Internship Program
Tuesday, September 16, 2008
BETHESDA, Md. — The Center for Prostate Disease Research (CPDR), Department of
Surgery, Uniformed Services University (USU) and the University of the District of Columbia
(UDC) were granted an award of $198,000 by the Department of Defense, United States Army
Medical Research and Materiel Command (USAMRMC) for training gifted students from the
University of the District of Columbia (UCD) in prostate cancer research.
Full Article
